COVID-19

cancel
Biotech

Moderna withdraws FDA filing for flu/COVID combination vaccine

The biotech plans to resubmit later this year with the phase 3 flu vaccine efficacy data the agency wants to see.
Nick Paul Taylor May 21, 2025 9:35am
Messenger RNA

Arcturus doubles down on mRNA, axes several early-stage assets

May 13, 2025 1:32pm
A hand with a blue glove reaches for the middle one of 12 vials with brightly-colored tops The vials appear to contain blood

Trump aims to block pathogen research, citing ‘lab leak’ theory

May 6, 2025 9:05pm
The particles polygonal geometric art - Vaccine abstract vector illustration

HHS unveils $500M universal vaccine development initiative

May 1, 2025 2:55pm
decision path change of plans arrows business decision

Moderna's flu/COVID vaccine hit by deprioritization, FDA delay

May 1, 2025 7:24am
stop light green

HHS lifts stop work order on Vaxart's COVID-19 trial

Apr 28, 2025 12:48pm
More News

Ex-FDA leader joins new initiative aiming to protect vaccine use

Apr 24, 2025 1:18pm

Expect further market correction in tariff-driven era: PitchBook

Apr 18, 2025 7:51am

HHS delivers stop work order to Atlanta biotech, pulls funding

Apr 16, 2025 11:02am

Vaxart lays off staffers after HHS demands halt to vaccine trial

Mar 21, 2025 8:36am